Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Referral

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    142 result(s) found for: Referral. Displaying page 1 of 8.
    1  2  3  4  5  6  7  8  Next»
    EudraCT Number: 2016-000473-20 Sponsor Protocol Number: CLCZ696B3402 Start Date*: 2016-08-18
    Sponsor Name:Novartis Pharma services AG
    Full Title: A prospective evaluation of natriuretic peptide based referral of CHF patients in primary care
    Medical condition: Chronic heart failure with reduced ejection fraction
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004849 10019279 Heart failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-017282-35 Sponsor Protocol Number: 113617 Start Date*: 2010-07-07
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: A phase IIIb, open, multi-centre gynaecological extension study for the follow-up of a subset of HPV-015 study subjects
    Medical condition: GSK Biologicals' HPV-16/18 L1 VLP AS04 vaccine is indicated in females from 10 years of age onwards for the prevention of pre-malignant cervical lesions and cervical cancer causally related to Hum...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) NL (Completed) PT (Completed)
    Trial results: View results
    EudraCT Number: 2014-004621-40 Sponsor Protocol Number: NL50760 Start Date*: 2015-09-07
    Sponsor Name:University Medical Center Groningen
    Full Title: The effect of oral ondansetron on referral rate in children aged 6 months to 6 years attending in primary care out of hours service with acute gastro-enteritis and vomiting.
    Medical condition: Gastroenteritis
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-005596-39 Sponsor Protocol Number: MPELONG Start Date*: 2022-09-07
    Sponsor Name:MAPS Europe B.V.
    Full Title: Long-Term Safety and Persistence of Effectiveness of Manualized MDMA Assisted Therapy for the Treatment of Posttraumatic Stress Disorder
    Medical condition: post-traumatic stress disorder (PTSD)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-015018-23 Sponsor Protocol Number: CACZ885H2356 Start Date*: 2009-12-21
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, controlled study of ACZ885 (canakinumab) on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/or colchicine are contraindicated, not tol...
    Medical condition: Treatment and prevention of gout flares in patients with frequent flares and for whom NSAIDs and/or colchicine are contraindicated, not tolerated or ineffective
    Disease: Version SOC Term Classification Code Term Level
    12.0 10018627 Gout LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) LV (Completed) LT (Completed) SE (Completed) EE (Completed) BE (Completed) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-017802-35 Sponsor Protocol Number: CACZ885H2357 Start Date*: 2010-03-04
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, controlled study of ACZ885 (canakinumab) on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not to...
    Medical condition: Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018627 Gout LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) LV (Completed) EE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-002642-35 Sponsor Protocol Number: SHR-5/S 04 Start Date*: 2006-03-08
    Sponsor Name:Green Medicine AB
    Full Title: A randomized double-blind placebo-controlled parallel group study of SHR -5 extract of Rhodiola Rosea as adjuvant therapy in patients with stress related fatigue.
    Medical condition: Burnout syndrome
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-001618-39 Sponsor Protocol Number: CL08-ORY-2001_COVID-19 Start Date*: 2020-04-24
    Sponsor Name:Oryzon Genomics S. A.
    Full Title: A Phase II, randomized, open–label study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress...
    Medical condition: Acute Respiratory Distress Syndrome (ARDS)
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004855 10003083 ARDS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2018-001597-16 Sponsor Protocol Number: none Start Date*: 2018-07-18
    Sponsor Name:Sitnikova Victoria
    Full Title: Efficacy of botulinum toxin in treating temporomandibular disorders
    Medical condition: Patients are diagnosed TMD (temporomandibular disorder) according to DC/TMD international consortium: myalgia, local myalgia, myofascial pain, myofascial pain with referral.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10028323 Muscle pains HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003868-22 Sponsor Protocol Number: RM/NEB/01-07 Start Date*: 2008-03-19
    Sponsor Name:Laboratoire Erempharma
    Full Title: ASSESMENT OG EFFICACY AND TOLERABILITY OF INHABLED TOBRAMYCIN VS PLACEBO IN CYSTIC FIBROSIS PATIENTS REVEIVING ANTIBIOTHERAPY FOR 28 DAYS FOR PSEUDOMONAS AERUGINOSA PRIMO COLONISATION.
    Medical condition: Assessment of microbiological efficacy and tolerability of inhaled tobramycin vs placebo in cystic fibrosis patients, primo colonised by Pseudomonas aeruginosa justified inhaled antiobiotherapeutic...
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004297-40 Sponsor Protocol Number: Version 3 February 2010 Start Date*: 2008-04-25
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: Pharmacological treatment of nystagmus: A randomised double masked placebo controlled crossover study using gabapentin and memantine.
    Medical condition: Nystagmus
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-023955-27 Sponsor Protocol Number: 34760 Start Date*: 2011-04-29
    Sponsor Name:Leiden University Medical Center
    Full Title: Randomized controlled trial on the use of rhEPO to reduce top-up transfusions in neonates with red blood cell alloimmunization
    Medical condition: hemolytic disease of the newborn due to red blood cell alloimmunization
    Disease:
    Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-001332-69 Sponsor Protocol Number: PG/04/100/17637 Start Date*: 2005-07-14
    Sponsor Name:University of Aberdeen
    Full Title: A randomised control trial of omega-3 fatty acid on platelet and endothelial function in patients with peripheral arterial disease
    Medical condition: Intermittent claudication
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-001990-25 Sponsor Protocol Number: BO1 Start Date*: 2004-09-06
    Sponsor Name:Bo Söderpalm
    Full Title: Hur påverkar Remeron alkoholkonsumtionen? How will Remeron influence alcohol consumption in high consumers?
    Medical condition: The subjects in the study will be recruited via an advertisment and will not have a diagnos. We will include males with high consumption of alcohol, defines as 400 grams or more of 100% alcohol per...
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003285-42 Sponsor Protocol Number: PHT/2005/37 Start Date*: 2005-11-28
    Sponsor Name:Portsmouth Institution Medicine, Health & Social Care, Portsmouth University [...]
    1. Portsmouth Institution Medicine, Health & Social Care, Portsmouth University
    2. Research & Development Unit, Queen Alexandra Hospital
    Full Title: A RCT to test the analgesic efficacy of topical morphine on minor and partial thickness burns in A&E
    Medical condition: Minor superficial and partial thickness burns <5% body surface area.
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-005087-24 Sponsor Protocol Number: Version 2 23/03/2005. Start Date*: 2005-07-11
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: CIMETIDINE IN THE TREATMENT OF CALCIFIC SUPRASPINATUS TENDINITIS- A TRIAL OF CIMETIDINE 200mg B.D IN THE RESOLUTION OF CALCIFICATION IN THE SUPRASINATUS TENDON.
    Medical condition: CALCIFIC SUPRASPINATUS TENDINITIS
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004514-17 Sponsor Protocol Number: 11111918 Start Date*: 2005-03-29
    Sponsor Name:Beroendcentrum Stockholm
    Full Title: Does Acamprosate Decrease Cue-induced Alcohol Craving?
    Medical condition: Alcohol dependence.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-024172-26 Sponsor Protocol Number: CACZ885H2358 Start Date*: 2011-08-08
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, double-dummy, active controlled study of ACZ885 (canakinumab) on the treatment and prevention of gout flares in patients with frequent flares, for whom NSAIDs and/or col...
    Medical condition: treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective
    Disease: Version SOC Term Classification Code Term Level
    17.0 10027433 - Metabolism and nutrition disorders 10018627 Gout PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2005-004835-23 Sponsor Protocol Number: TON/01/05-CLIN Start Date*: 2006-01-26
    Sponsor Name:Minster Pharmaceuticals Ltd
    Full Title: Multi-centre, parallel group, double-blind, placebo controlled study of the efficacy and tolerability of TONABERSAT in prophylaxis of migraine headache
    Medical condition: Migraine with or without aura meeting the diagnostic criteria of the International Classification of Headache Disorders (Edition 2).
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed) DK (Completed) GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2016-002118-40 Sponsor Protocol Number: PPL07 Start Date*: 2018-02-23
    Sponsor Name:Dilafor AB
    Full Title: Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Effect of continuous infusion of Tafoxiparin as an Adjunct Treatment to Oxytocin for up to 36 hours...
    Medical condition: Primary Slow Progress of Labor including prolonged latent phase and Primary Labor Arrest
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004868 10023539 Labor abnormal LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) FI (Completed) DK (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 13:26:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA